Showing results (131-140 of 225) with videos related to

Sort By:
Pageof 23
The Journal of Biological Chemistry|November 2, 2018
The aryl hydrocarbon receptor-cytochrome P450 1A1 pathway controls lipid accumulation and enhances the permissiveness for hepatitis C virus assemblyHirofumi Ohashi, Kazane Nishioka, Syo Nakajima, et al.
The Journal of Antibiotics|December 13, 2022
Isolation, structural determination, and antiviral activities of metabolites from vanitaracin A-producing Talaromyces spShinji Kamisuki, Hisanobu Shibasaki, Hironobu Murakami, et al.
Plos Pathogens|January 16, 2026
Structural mapping of NTCP distinguishes its dual functionality as a hepatitis B virus receptor and bile acid transporterKayo Matsuzawa, Toru Ekimoto, Chisa Kobayashi, et al.
Hepatology (Baltimore, Md.)|January 12, 2021
Dual Agonist of Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In VivoKiyoaki Ito, Akinori Okumura, Junko S Takeuchi, et al.
Biodesign Research|March 22, 2024
Harnessing a T1 Phage-Derived Spanin for Developing Phage-Based Antimicrobial DevelopmentWakana Yamashita, Shinjiro Ojima, Azumi Tamura, et al.
Iscience|February 28, 2020
Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B VirusSatoko Matsunaga, Sundararaj S Jeremiah, Kei Miyakawa, et al.
Bioscience, Biotechnology, and Biochemistry|October 8, 2019
Synthesis of nucleotide analogues, EFdA, EdA and EdAP, and the effect of EdAP on hepatitis B virus replicationMai Kamata, Toshifumi Takeuchi, Ei Hayashi, et al.
Plos One|June 13, 2019
An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genesYutaka Furutani, Mariko Toguchi, Yumi Shiozaki-Sato, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 2, 2020
Screening siRNAs against host glycosylation pathways to develop novel antiviral agents against hepatitis B virusKiyoaki Ito, Kiyohiko Angata, Atsushi Kuno, et al.
Chemical & Pharmaceutical Bulletin|November 1, 2023
Anti-hepatitis C Virus Activity of Juglorubin DerivativesHirofumi Ohashi, Kazane Nishioka, Tomoki Kurihara, et al.
Pageof 23